Cristina Di Primio

Dr. Cristina Di Primio

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Cell Host & Microbe
Verified
Journal Article
Closed access
AAAwatef Allouch
Awatef Allouch
CPCristina Di Primio
Cristina Di Primio
EAEmanuele Alpi
Emanuele Alpi
MLMarina Lusic
Marina Lusic
DADaniele Arosio
Daniele Arosio
ACAnna Cereseto
Anna Cereseto

12 March 2010 in Retrovirology
Verified
Journal Article
Open access
PDF file
MTMariaelena Terreni
Mariaelena Terreni
PVPaola Valentini
Paola Valentini
VLVania Liverani
Vania Liverani
MGMaria Ines Gutierrez
Maria Ines Gutierrez
CPCristina Di Primio
Cristina Di Primio
ACAnna Cereseto
Anna Cereseto
Background: An essential event during the replication cycle of HIV-1 is the integration of the reverse transcribed viral DNA into the host cellular genome. Our former report revealed that HIV-1 integrase (IN), the enzyme that catalyzes the integration reaction, is positively regulated by acetylation mediated by the histone acetyltransferase (HAT) p300. Results: In this study we demonstrate that another cellular HAT, GCN5, acetylates IN leading to enhanced 3'-end processing and strand transfer activities. GCN5 participates in the integration step of HIV-1 replication cycle as demonstrated by the reduced infectivity, due to inefficient provirus formation, in GCN5 knockdown cells. Within the C-terminal domain of IN, four lysines (K258, K264, K266, and K273) are targeted by GCN5 acetylation, three of which (K264, K266, and K273) are also modified by p300. Replication analysis of HIV-1 clones carrying substitutions at the IN lysines acetylated by both GCN5 and p300, or exclusively by GCN5, demonstrated that these residues are required for efficient viral integration. In addition, a comparative analysis of the replication efficiencies of the IN triple- and quadruple-mutant viruses revealed that even though the lysines targeted by both GCN5 and p300 are required for efficient virus integration, the residue exclusively modified by GCN5 (K258) does not affect this process. Conclusions: The results presented here further demonstrate the relevance of IN post-translational modification by acetylation, which results from the catalytic activities of multiple HATs during the viral replication cycle. Finally, this study contributes to clarifying the recent debate raised on the role of IN acetylated lysines during HIV-1 infection.

19 March 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CPCristina Di Primio
Cristina Di Primio
VQValentina Quercioli
Valentina Quercioli
AAAwatef Allouch
Awatef Allouch
RGRik Gijsbers
Rik Gijsbers
FCFrauke Christ
Frauke Christ
ACAnna Cereseto
Anna Cereseto
Recent advances in fluorescence microscopy provided tools for the investigation and the analysis of the viral replication steps in the cellular context. In the HIV field, the current visualization systems successfully achieve the fluorescent labeling of the viral envelope and proteins, but not the genome. Here, we developed a system able to visualize the proviral DNA of HIV-1 through immunofluorescence detection of repair foci for DNA double-strand breaks specifically induced in the viral genome by the heterologous expression of the I-SceI endonuclease. The system for Single-Cell Imaging of HIV-1 Provirus, named SCIP, provides the possibility to individually track integrated-viral DNA within the nuclei of infected cells. In particular, SCIP allowed us to perform a topological analysis of integrated viral DNA revealing that HIV-1 preferentially integrates in the chromatin localized at the periphery of the nuclei.

1 February 2019 in Journal of Molecular Biology
Verified
Journal Article
Open access
GSGiacomo Siano
Giacomo Siano
MVMartina Varisco
Martina Varisco
MCMaria Claudia Caiazza
Maria Claudia Caiazza
VQValentina Quercioli
Valentina Quercioli
MMMarco Mainardi
Marco Mainardi
CPCristina Di Primio
Cristina Di Primio
Tau displacement from microtubules is the first step in the onset of tauopathies and is followed by toxic protein aggregation. However, other non-canonical functions of Tau might have a role in these pathologies. Here, we demonstrate that a small amount of Tau localizes in the nuclear compartment and accumulates in both the soluble and chromatin-bound fractions. We show that favoring Tau nuclear translocation and accumulation, by Tau overexpression or detachment from MTs, increases the expression of VGluT1, a disease-relevant gene directly involved in glutamatergic synaptic transmission. Remarkably, the P301L mutation, related to frontotemporal dementia FTDP-17, impairs this mechanism leading to a loss of function. Altogether, our results provide the demonstration of a direct physiological role of Tau on gene expression. Alterations of this mechanism may be at the basis of the onset of neurodegeneration.

2 August 2005 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CPCristina Di Primio
Cristina Di Primio
Alvaro GalliAlvaro Galli
Alvaro Galli
TCTiziana Cervelli
Tiziana Cervelli
MZMonica Zoppè
Monica Zoppè
GRGiuseppe Rainaldi
Giuseppe Rainaldi
When exogenous DNA is stably introduced in mammalian cells, it is typically integrated in random positions, and only a minor fraction enters a pathway of homologous recombination (HR). The complex Rad51/Rad52 is a major player in the management of exogenous DNA in eukaryotic organisms and plays a critical role in the choice of repair system. In Saccharomyces cerevisiae, the pathway of choice is HR, mediated by Rad52 (ScRad52), which differs slightly from its human homologue. Here, we present an approach that utilizes ScRad52 to enhance HR in human cells containing a specific substrate for recombination. Clones of HeLa cells were produced expressing functional ScRad52. These cells showed enhanced resistance to DNA damaging treatments and revealed a different distribution of Rad51 foci (a marker of recombination complex formation). More significantly, ScRad52 expression resulted in an up to 37-fold increase in gene targeting by HR. In the same cells, random integration of exogenous DNA was significantly reduced, consistent with the view that HR and non-homologous end joining are alternative competing pathways. Expression of ScRad52 could offer a major improvement for experiments requiring gene targeting by HR, both in basic research and in gene therapy studies.

21 August 2019 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
GSGiacomo Siano
Giacomo Siano
MCMaria Claudia Caiazza
Maria Claudia Caiazza
IOIvana Ollà
Ivana Ollà
MVMartina Varisco
Martina Varisco
GMGiuseppe Madaro
Giuseppe Madaro
CPCristina Di Primio
Cristina Di Primio
Formation of Tau aggregates is a common pathological feature of tauopathies and their accumulation directly correlates with cytotoxicity and neuronal degeneration. Great efforts have been made to understand Tau aggregation and to find therapeutics halting or reversing the process, however, progress has been slowed due to the lack of a suitable method for monitoring Tau aggregation. We developed a cell-based assay allowing to detect and quantify Tau aggregation in living cells. The system is based on the FRET biosensor CST able to monitor the molecular dynamic of Tau aggregation in different cellular conditions. We probed candidate compounds that could block Tau hyperphosphorylation. In particular, to foster the drug discovery process, we tested kinase inhibitors approved for the treatment of other diseases. We identified the ERK inhibitor PD-901 as a promising therapeutic molecule since it reduces and prevents Tau aggregation. This evidence establishes the CST cell-based aggregation assay as a reliable tool for drug discovery and suggests that PD-901 might be a promising compound to be tested for further preclinical studies on AD.